Department of Plastic and Reconstructive Surgery, Center for Vascularized Composite Allotransplantation, Chang Gung Memorial Hospital, Chang Gung Medical College and Chang Gung University, Taoyuan, Gueishan, Taiwan.
Department of Pathology, Chang Gung Memorial Hospital, Chang Gung Medical College and Chang Gung University, Taoyuan, Gueishan, Taiwan.
Transplantation. 2021 Jun 1;105(6):1238-1249. doi: 10.1097/TP.0000000000003509.
The role of regulatory T cells (Treg) in tolerance induction of vascularized composite allotransplantation (VCA) remains unclear. This study was designed to examine characteristics of Treg after VCA and their capacity to rescue allografts from rejection.
Osteomyocutaneous allografts were transplanted from Balb/c to C57BL/6 mice. All mice received costimulatory blockade and a short course of rapamycin. To elucidate the role of Treg for tolerance induction, Treg depletion was performed at postoperative day (POD) 0, 30, or 90. To assess capacity of Treg to rescue allografts from rejection, an injection of 2 × 106 Treg isolated from tolerant mice was applied.
Eighty percent of VCA recipient mice using costimulatory blockade and rapamycin regimen developed tolerance. The tolerant recipients had a higher ratio of circulating Treg to effector T cells and elevated interleukin-10 at POD 30. A significantly higher rejection rate was observed when Treg were depleted at POD 30. But Treg depletion at POD 90 had no effect on tolerance. Treg from tolerant recipients showed stronger suppressive potential and the ability to rescue allografts from rejection. Furthermore, transplanted Treg-containing skin grafts from tolerant mice delayed rejection elicited by adoptively transferred effector T cells to Rag2-/- mice.
Circulating Treg are crucial for inducing VCA tolerance in the early posttransplant phase, and allograft-residing Treg may maintain tolerance. Treg may, therefore, serve as a potential cellular therapeutic to improve VCA outcomes.
调节性 T 细胞(Treg)在血管化复合组织同种异体移植(VCA)中的耐受诱导作用尚不清楚。本研究旨在研究 VCA 后 Treg 的特征及其从排斥中拯救同种异体移植物的能力。
从 Balb/c 向 C57BL/6 小鼠移植了肌皮同种异体移植物。所有小鼠均接受共刺激阻断和短期雷帕霉素治疗。为了阐明 Treg 诱导耐受的作用,在术后第 0、30 或 90 天进行 Treg 耗竭。为了评估 Treg 从排斥中拯救同种异体移植物的能力,将从耐受小鼠中分离的 2×106 Treg 注射。
使用共刺激阻断和雷帕霉素方案的 80%VCA 受者小鼠发展为耐受。耐受受者在术后第 30 天具有更高的循环 Treg 与效应 T 细胞的比例,并且白细胞介素-10 升高。当在 POD 30 时耗竭 Treg 时,观察到明显更高的排斥率。但是在 POD 90 时 Treg 耗竭对耐受没有影响。来自耐受受者的 Treg 显示出更强的抑制潜能和从排斥中拯救同种异体移植物的能力。此外,来自耐受小鼠的含有移植 Treg 的皮肤移植物延迟了向 Rag2-/- 小鼠过继转移效应 T 细胞引发的排斥。
循环 Treg 是在移植后早期诱导 VCA 耐受的关键,同种异体移植物驻留的 Treg 可能维持耐受。因此,Treg 可作为一种潜在的细胞治疗方法来改善 VCA 结果。